215 related articles for article (PubMed ID: 12886478)
1. [Quantifying the inflammatory activity in Crohn's disease using CE dynamic MRI].
Pauls S; Kratzer W; Rieber A; Schmidt SA; Mittrach C; Adler G; Brambs HJ; Gabelmann A
Rofo; 2003 Aug; 175(8):1093-9. PubMed ID: 12886478
[TBL] [Abstract][Full Text] [Related]
2. Measurement of MRI enhancement kinetics for evaluation of inflammatory activity in Crohn's disease.
Röttgen R; Grandke T; Grieser C; Lehmkuhl L; Hamm B; Lüdemann L
Clin Imaging; 2010; 34(1):29-35. PubMed ID: 20122516
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of inflammatory activity in Crohn disease with hydro-MRI].
Schunk K; Kern A; Heussel CP; Kalden P; Mayer I; Orth T; Wanitschke R
Rofo; 2000 Feb; 172(2):153-60. PubMed ID: 10723489
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-FISP as new gold standard?].
Hohl C; Haage P; Krombach GA; Schmidt T; Ahaus M; Günther RW; Staatz G
Rofo; 2005 Jun; 177(6):856-63. PubMed ID: 15902636
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease.
Del Vescovo R; Sansoni I; Caviglia R; Ribolsi M; Perrone G; Leoncini E; Grasso RF; Cicala M; Zobel BB
Abdom Imaging; 2008; 33(4):417-24. PubMed ID: 17639383
[TBL] [Abstract][Full Text] [Related]
7. MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease.
Laghi A; Paolantonio P; Iafrate F; Borrelli O; Dito L; Tomei E; Cucchiara S; Passariello R
Radiol Med; 2003; 106(1-2):18-27. PubMed ID: 12951547
[TBL] [Abstract][Full Text] [Related]
8. [MR-Imaging of lower leg muscle perfusion].
Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn's disease.
Florie J; Wasser MN; Arts-Cieslik K; Akkerman EM; Siersema PD; Stoker J
AJR Am J Roentgenol; 2006 May; 186(5):1384-92. PubMed ID: 16632735
[TBL] [Abstract][Full Text] [Related]
11. Crohn's disease. Pilot study comparing MRI of the abdomen with clinical evaluation.
Kettritz U; Isaacs K; Warshauer DM; Semelka RC
J Clin Gastroenterol; 1995 Oct; 21(3):249-53. PubMed ID: 8648064
[TBL] [Abstract][Full Text] [Related]
12. MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum.
Girometti R; Zuiani C; Toso F; Brondani G; Sorrentino D; Avellini C; Bazzocchi M
Acad Radiol; 2008 Feb; 15(2):153-64. PubMed ID: 18206614
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease.
Rimola J; Rodriguez S; García-Bosch O; Ordás I; Ayala E; Aceituno M; Pellisé M; Ayuso C; Ricart E; Donoso L; Panés J
Gut; 2009 Aug; 58(8):1113-20. PubMed ID: 19136510
[TBL] [Abstract][Full Text] [Related]
14. [Magnetic resonance imaging of the small intestine and colon in Crohn's disease].
Rollandi GA; Martinoli C; Conzi R; Cittadini G; Molinari F; Bertolotto M; Talenti A; Curone P
Radiol Med; 1996; 91(1-2):81-5. PubMed ID: 8614737
[TBL] [Abstract][Full Text] [Related]
15. MRI evaluation of inflammatory activity in Crohn's disease.
Sempere GA; Martinez Sanjuan V; Medina Chulia E; Benages A; Tome Toyosato A; Canelles P; Bulto A; Quiles F; Puchades I; Cuquerella J; Celma J; Orti E
AJR Am J Roentgenol; 2005 Jun; 184(6):1829-35. PubMed ID: 15908538
[TBL] [Abstract][Full Text] [Related]
16. Role of spectral presaturation attenuated inversion-recovery fat-suppressed T2-weighted MR imaging in active inflammatory bowel disease.
Udayasankar UK; Martin D; Lauenstein T; Rutherford R; Galloway J; Tudorascu D; Sitaraman SV
J Magn Reson Imaging; 2008 Nov; 28(5):1133-40. PubMed ID: 18972354
[TBL] [Abstract][Full Text] [Related]
17. [Hydro-MRI in inflammatory bowel diseases: a comparison with colonoscopy and histology].
Schunk K; Reiter S; Kern A; Orth T; Wanitschke R
Rofo; 2001 Aug; 173(8):731-8. PubMed ID: 11570244
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced MRI in patients with luminal Crohn's disease.
Ziech ML; Lavini C; Caan MW; Nio CY; Stokkers PC; Bipat S; Ponsioen CY; Nederveen AJ; Stoker J
Eur J Radiol; 2012 Nov; 81(11):3019-27. PubMed ID: 22749801
[TBL] [Abstract][Full Text] [Related]
19. Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI.
Pupillo VA; Di Cesare E; Frieri G; Limbucci N; Tanga M; Masciocchi C
Radiol Med; 2007 Sep; 112(6):798-809. PubMed ID: 17885739
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of renal artery stenosis in 1.0 T using 3D phase contrast magnetic resonance angiography and dynamic contrast medium perfusion].
Miller S; Hahn U; Schick F; Nägele T; Duda SH; Eckstein FS; Scheule AM; Claussen CD
Rofo; 1999 Feb; 170(2):163-7. PubMed ID: 10101356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
